An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study
Study sponsor: CytoDyn, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-06Actual
Enrollment · participants43Actual
Source updated2025-11-12Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.